Cargando…

Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden

SIMPLE SUMMARY: The incidence of invasive cutaneous melanoma (CM) is increasing in Sweden. The aim was to present age- and sex-specific trends of the age-standardised incidence and the average annual percentage change (AAPC) for in situ and invasive CM by analysing data obtained from the Swedish Mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Hanna, Nielsen, Kari, Vassilaki, Ismini, Lapins, Jan, Mikiver, Rasmus, Lyth, Johan, Isaksson, Karolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201382/ https://www.ncbi.nlm.nih.gov/pubmed/34200396 http://dx.doi.org/10.3390/cancers13112838

Ejemplares similares

The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden
por: Eriksson, Hanna, et al.
Publicado: (2021)

Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
por: Isaksson, Karolin, et al.
Publicado: (2019)

The impact of standardized care pathway on reporting time for invasive melanoma – results from one pathology department in Sweden
por: Agnarsdóttir, Margrét, et al.
Publicado: (2019)

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
por: Helgadottir, Hildur, et al.
Publicado: (2023)

The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study
por: Katsarelias, Dimitrios, et al.
Publicado: (2020)

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228
por: Katsarelias, Dimitrios, et al.
Publicado: (2020)

Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
por: INGVAR, Åsa, et al.
Publicado: (2020)

Perception of information to Swedish melanoma patients in routine clinical practice – a cross-sectional survey
por: Tufvesson Stiller, Helena, et al.
Publicado: (2022)

Interobserver Agreement on Dermoscopic Features and their Associations with In Situ and Invasive Cutaneous Melanomas
por: POLESIE, Sam, et al.
Publicado: (2021)

Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma
por: Kim, Jinah, et al.
Publicado: (2011)

New Trends in Cutaneous Melanoma Surgery
por: Scala, Jacopo, et al.
Publicado: (2019)

Socio-economic class, rurality and risk of cutaneous melanoma by site and gender in Sweden
por: Pérez-Gómez, Beatriz, et al.
Publicado: (2008)

Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study
por: Indremo, Malin, et al.
Publicado: (2021)

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020)

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
por: Mitra, Shamik, et al.
Publicado: (2020)

Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma
por: Sanna, Adriana, et al.
Publicado: (2019)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Actinic Keratosis Diagnosis and Increased Risk of Developing Skin Cancer: A 10-year Cohort Study of 17,651 Patients in Sweden
por: GUORGIS, Ghassan, et al.
Publicado: (2020)

Plasma proteome alterations by MAPK inhibitors in BRAF(V600)-mutated metastatic cutaneous melanoma()()
por: Babačić, Haris, et al.
Publicado: (2021)

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
por: Svedman, Fernanda Costa, et al.
Publicado: (2018)

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
por: Wassberg, C., et al.
Publicado: (1996)

Trends in renal function in Northern Sweden 1986–2014: data from the seven cross-sectional surveys within the Northern Sweden MONICA study
por: de Man Lapidoth, Julia, et al.
Publicado: (2023)

Shifting Trends in Cutaneous and Aesthetic Surgery: A Need for Caution and Regulation
por: Khunger, Niti
Publicado: (2016)

Trends in mortality rates of cutaneous melanoma in East Asian populations
por: Chen, Ling, et al.
Publicado: (2016)

Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma
por: El Sharouni, Mary-Ann, et al.
Publicado: (2019)

Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
por: Naik, Piyu Parth
Publicado: (2021)

Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile
por: Buja, Alessandra, et al.
Publicado: (2022)

Trends in cutaneous melanoma mortality in Italy from 1982 to 2016
por: Briatico, Giulia, et al.
Publicado: (2022)

Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010–2019
por: Cohen, Jacqueline M., et al.
Publicado: (2022)

Late adverse events in patients with pelvic cancer after oncologic treatment—intervention and treatment effect
por: Iselius, Sofia, et al.
Publicado: (2023)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

Amelanotic Melanoma Concealed by Psoriasis
por: CURMAN, Philip, et al.
Publicado: (2020)

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers
por: Pissa, Maria, et al.
Publicado: (2022)

CD207+/langerin positive dendritic cells in invasive and in situ cutaneous malignant melanoma
por: Dyduch, Grzegorz, et al.
Publicado: (2017)

Mortality from cutaneous melanoma: evidence for contrasting trends between populations
por: Severi, G, et al.
Publicado: (2000)

Trends and projections in cutaneous melanoma death in the Netherlands from 1950 to 2045
por: van Niekerk, Catharina C., et al.
Publicado: (2021)

Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.
por: Thörn, M., et al.
Publicado: (1992)

Trends in hip replacements between 1999 and 2012 in Sweden
por: Cnudde, Peter, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5562tavctbm6mtreg35b8nomt2